Chongqing Zhifei Biological Products Co., Ltd. Share Price
Equities
300122
CNE100000V20
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.93 CNY | +0.88% |
|
-5.51% | -20.88% |
| Capitalization | 3.57TCr 524.71Cr 452.56Cr 414.56Cr 391.73Cr 722.18Cr 51TCr 740.36Cr 4.94TCr 1.92TCr 24TCr 1.97TCr 1.93TCr 84TCr | P/E ratio 2026 * |
-23.1x | P/E ratio 2027 * | -82.6x |
|---|---|---|---|---|---|
| Enterprise value | 4.44TCr 651.92Cr 562.28Cr 515.08Cr 486.71Cr 897.28Cr 63TCr 919.86Cr 6.14TCr 2.39TCr 30TCr 2.45TCr 2.39TCr 1,03800Cr | EV / Sales 2026 * |
5.28x | EV / Sales 2027 * | 4.85x |
| Free-Float |
14.76% | Yield 2026 * |
-
| Yield 2027 * | 0.09% |
| 1 day | +0.88% | ||
| 1 week | -5.51% | ||
| Current month | -1.45% | ||
| 1 month | -3.49% | ||
| 3 months | -11.66% | ||
| 6 months | -28.36% | ||
| Current year | -20.88% |
| 1 week | 14.7 |  | 15.86 |
| 1 month | 14.57 | | 16.76 |
| Current year | 14.45 | | 20.89 |
| 1 year | 14.45 | | 26 |
| 3 years | 14.45 | | 70.27 |
| 5 years | 14.45 | | 142.63 |
| 10 years | 8.2 | | 154.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ling Feng Jiang
CEO | Chief Executive Officer | 46 | 20/09/2024 |
Zhen Jing Li
DFI | Director of Finance/CFO | 44 | 19/08/2015 |
Dan Qing Leng
CMP | Compliance Officer | 40 | 01/01/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Ren Sheng Jiang
CHM | Chairman | 73 | 17/08/2009 |
Ling Feng Jiang
BRD | Director/Board Member | 46 | 10/08/2018 |
Zhen Jing Li
BRD | Director/Board Member | 44 | 10/04/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | -5.51% | -23.32% | -69.87% | 524.71Cr | |
| +0.10% | -12.87% | +5.66% | -16.96% | 6.41TCr | |
| +1.49% | -0.29% | +47.98% | +173.08% | 5.18TCr | |
| -2.89% | +34.60% | +34.60% | +34.60% | 4.13TCr | |
| -0.22% | -0.32% | -59.65% | -67.95% | 3.39TCr | |
| -0.70% | -4.41% | +47.22% | -38.23% | 2.81TCr | |
| -4.97% | -14.17% | +73.25% | -63.78% | 1.81TCr | |
| +0.43% | -3.56% | +49.82% | +50.39% | 1.91TCr | |
| -0.75% | -8.79% | +43.58% | +104.38% | 1.77TCr | |
| +0.60% | -0.50% | +40.59% | +82.75% | 1.6TCr | |
| Average | -0.17% | -5.72% | +25.97% | +18.84% | 2.95TCr | |
| Weighted average by Cap. | -0.24% | -6.12% | +24.23% | +28.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 840.61Cr 123.41Cr 106.44Cr 98Cr 92Cr 169.86Cr 12TCr 174.14Cr 1.16TCr 452.52Cr 5.62TCr 463.12Cr 453.25Cr 20TCr | 898.17Cr 131.86Cr 113.73Cr 104.18Cr 98Cr 181.49Cr 13TCr 186.06Cr 1.24TCr 483.51Cr 6.01TCr 494.84Cr 484.29Cr 21TCr |
| Net income | -154.98Cr -23Cr -20Cr -18Cr -17Cr -31Cr -2.2TCr -32Cr -214.24Cr -83Cr -1.04TCr -85Cr -84Cr -3.62TCr | -43Cr -6.36Cr -5.48Cr -5.02Cr -4.75Cr -8.75Cr -615.6Cr -8.97Cr -60Cr -23Cr -289.79Cr -24Cr -23Cr -1.01TCr |
| Net Debt | 866.51Cr 127.22Cr 109.72Cr 100.51Cr 95Cr 175.1Cr 12TCr 179.5Cr 1.2TCr 466.47Cr 5.8TCr 477.39Cr 467.22Cr 20TCr | 778.1Cr 114.24Cr 99Cr 90Cr 85Cr 157.23Cr 11TCr 161.19Cr 1.08TCr 418.87Cr 5.21TCr 428.69Cr 419.55Cr 18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | 14.93 ¥ | +0.88% | 1,17,21,260 |
| 18/26/18 | 14.80 ¥ | -1.60% | 1,51,49,150 |
| 15/26/15 | 15.04 ¥ | -0.33% | 1,85,40,640 |
| 14/26/14 | 15.09 ¥ | -3.27% | 2,49,16,270 |
| 13/26/13 | 15.60 ¥ | -1.27% | 2,09,71,940 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300122 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition